Proton beam and carbon ion radiotherapy in skull base chordoma: a systematic review, meta-analysis and meta-regression with trial sequential analysis
2024

Proton and Carbon Ion Therapy for Skull Base Chordoma

Sample size: 1145 publication Evidence: moderate

Author Information

Author(s): Rodrigues Amanda Cyntia Lima Fonseca, Tos Salem M., Shaaban Ahmed, Mantziaris Georgios, Trifiletti Daniel M.

Hypothesis

This systematic review and meta-analysis aimed to analyze the efficacy and safety of proton beam therapy (PBT) and carbon ion radiotherapy (CIRT) for skull base chordoma.

Conclusion

Both PBT and CIRT are effective treatments for skull base chordoma, with comparable long-term efficacy.

Supporting Evidence

  • No significant difference was found between PBT and CIRT for 5-year local control and overall survival.
  • At 3 years, PBT showed an advantage in local control (90% vs. 83% for CIRT; p=0.05).
  • Both therapies demonstrated comparable progression-free survival rates.

Takeaway

Doctors studied two types of radiation therapy for a rare tumor in the skull and found that both work well, but they need to choose the best one for each patient.

Methodology

A systematic search of MEDLINE, EMBASE, CENTRAL, Web of Science, and Ovid was conducted, including studies with more than 10 patients treated with PBT or CIRT.

Potential Biases

Publication bias was suggested by asymmetrical funnel plots.

Limitations

Most studies are retrospective, leading to variability in practice protocols and patient referral patterns; long-term follow-up is required to assess treatment efficacy.

Participant Demographics

The median age of participants ranged from 13 to 58 years, with a male to female ratio of 1.21.

Statistical Information

P-Value

0.05

Confidence Interval

95% CI = 0.83 to 0.97

Statistical Significance

p=0.05

Digital Object Identifier (DOI)

10.1007/s10143-024-03117-1

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication